I t is unclear whether the increase in availability of substrates for energy production in diabetes can lead to enhanced systolic function early in the disease, before the onset of structural changes to the myocardium. To examine this issue, BKS.Cg-m +/+ Lepr db (db/db) mice with type 2 diabetes and wild type controls had left ventricular pressure-volume relationships determined in situ. We demonstrated that the db/db mice, when compared to their wild type controls, generated greater left ventricular pressure and an enhancement of left ventricular systolic function based on enhanced power/EDV, positive dP/dt, preload recruitable stroke work, dP/dt -EDV relationship, and curvilinear end-systolic elastance. This enhancement in systolic function occurred despite the db/db mice having greater body weight, but similar preload (end-diastolic volume) and afterload (effective arterial elastance).
Introduction
Type 2 diabetes is associated with myocardial disease. This is in part due to atherosclerosis and hypertension. There is also evidence for diabetes having a direct impact on the myocardium, with documentation of diabetes-induced diastolic dysfunction based on echocardiographic studies in patients. 1 However, whether diabetes can cause myocardial dilation and secondary cardiomyopathy is more controversial. Since the variables of atherosclerosis and hypertension cannot be removed in patients, investigators have focused on animal models of type 2 diabetes to study the impact of diabetes on myocardial disease more directly.
Both the BKS.Cg-m +/+ Lepr db (db/db) mouse and obese Zucker rat (fa/fa) rat are well established animal models of insulin resistance. [2] [3] [4] Neither model develops coronary artery disease. These animal models have been used to investigate the myocardial impact of type 2 diabetes. 5, 6 Using isolated perfused hearts, the Zucker rat showed increased left ventricular pressure (LVP) and its first derivative dP/dt (contractility). 7 The increase in myocardial function was further enhanced with the addition of insulin to the perfusate, which more closely approximated the in situ insulin concentration. 7 In contrast, isolated hearts of db/db mice showed decreased cardiac function. 8 The reduced function was confirmed in db/db hearts in situ using echocardiography. 9 Thus, it is not clear from the literature whether, early in diabetes, there is increased or decreased LV systolic function.
The explanation for these differences in systolic function in the isolated hearts may be related to whether the perfusate simulated the in situ diabetic milieu. The weaker isolated db/db hearts were placed in a perfusate, which had no insulin and low concentrations of free fatty acids. In contrast, the stronger isolated Zucker rat hearts were placed in a perfusate more representative of the diabetic milieu. Further, although the in situ db/db hearts evaluated by echocardiography demonstrated reduced function, the investigators used load-dependent measures of systolic function, which could be reduced due to increased afterload. Blood pressure and other measures of afterload were not reported in this study. 9 The diabetic heart does not demonstrate resistance to insulin, unlike skeletal muscle. 10 Thus, not only is the increased free fatty acid content of diabetic blood available to the heart for energy generation but increased glucose is available as well. We hypothesise that early in diabetes, before the onset of structural myocardial damage, there is increased energy supply to the heart in the form of increased ORIGINAL ARTICLE Enhanced left ventricular systolic function early in type 2 diabetic mice: clinical implications free fatty acids and glucose. We postulate that the heart could have enhanced systolic function, rather than reduced function, early in diabetes due to increased energy supply. To demonstrate this, it is important to use load-independent measures of left ventricular function. With the recent advent of the miniaturised mouse conductance system, 11, 12 it is now technically feasible to measure LV pressure-volume relationships in the in situ murine heart. We chose to study the well characterised db/db mouse model with this new instrumentation.
Methods
Conductance technology A 1.4 French miniaturised pressure-volume catheter (SPR-719, Millar Instruments, Houston, TX) was used in these studies. A constant excitation current (17µA root mean square) was applied to the outermost electrodes at two frequencies simultaneously, 10 and 100 kHz. The device uses a custom signal generator/processor and bridge amplifiers developed by us and modified by Millar Instruments (Houston, Texas). The 10 and 100 kHz frequencies are generated with a Signametrics SM-1030 Complex DDS Generator (Seattle, WA). The theory behind the determination of volume using the conductance catheter system in larger animals has been described in detail. 13, 14 The use of dual frequency to determine instantaneous parallel conductance in mice has also been described. 11 The only additional instrumentation used in conjunction with the dual frequency conductance system was an aortic flow probe, used to correct for electrical field inhomogeneity (α).
Husbandry
The Institutional Animal Care and Use Committee at the University of Texas Health Science Center at San Antonio approved all experiments. Female BKS.Cg-m +/+ Lepr db (db/db) mice (n=7), as well as their female non-diabetic littermates (db/+ or +/+) (n=9), were used in these studies. Breeder pairs (db/+ x db/+) were purchased from Jackson Laboratory (Bar Harbor, ME) and used to generate offspring, who were all studied at 11 weeks of age. All mice were given access to food and water ad libitum.
Haemodynamic protocol
Mice were anaesthetised with a combination of urethane (1,000 mg/kg, i.p.) and etomidate (25 mg/kg, i.p.). Blood glucose concentrations were obtained using tail blood samples and measured with a Life Scan One Touch Basic, Johnson & Johnson (Milpites, CA). Body weight was then recorded. Mice were placed on a temperature-controlled operating table for small animals (Vestavia Scientific, Ill.) and then mechanically ventilated with a rodent ventilator set at 150 breaths/min (100 % O 2 ). In half the mice, physiological temperatures were utilised (37°C, n=8), while the other half were studied at room temperature (31°C, n=8). The db/db and wild type (WT) mice were equally distributed between these two temperatures.
The chest was entered via an anterior thoracotomy. An apical stab was made in the heart with a 30-G needle, and the miniaturised conductance catheter (Millar Instruments, Houston, TX) was advanced retrograde into the left ventricle (LV) along the long axis, with the proximal electrode just within the myocardial wall at the apex. The inferior vena cava (IVC) was isolated immediately below the diaphragm for transient occlusion.
Baseline pressure-conductance relationships at both 10 and 100 kHz were acquired and stored for offline conversion to pressure-volume relationships. Similar data were acquired during transient occlusion of the IVC. To derive α at the end of the experiment, a small animal blood flow meter T 106 (Transonic Systems Inc., Ithica, NY) was placed around the ascending aorta. Simultaneous LV conductance at 10 and 100 kHz and aortic flow were recorded.
Myocardial resistivity protocol
It has been previously shown that the myocardial resistivity of the in vivo db/db myocardium is different from the wild type myocardial resistivity. 15 It has also been shown that if the wild type myocardial resistivity is used to calculate db/db absolute LV volumes with the dual frequency conductance system, non-physiological (negative) volumes are obtained. 15 Thus, we also sought to determine myocardial resistivity in additional mice (db/db, n=6; wild type, n=7), also at 11 weeks of age. The myocardial resistivity was determined at 1, 10 and 100 kHz and then used with published algorithms to extract true instantaneous LV volume. 11 The protocol used to determine db/db and wild type myocardial resistivity was similar to the haemodynamics studies described above. It differed in that, once the anterior thoracotomy was complete, a custom four-electrode epicardial resistivity probe was applied to the in situ beating murine epicardium. Frequencies of one, 10 and 100 kHz were applied to electrodes one and four, and the instantaneous voltage between electrodes two and three was recorded. The voltage to conductivity relationship had previously been determined in saline solutions spanning the conductivity of the murine myocardium. In this manner, the real time myocardial voltage signal was converted to conductivity. Since the inverse of conductivity is resistivity, the data are expressed in resistivity (ohms-cm).
Data analysis
The pressure-volume data were analysed with software developed by us, and licensed to and modified by Millar Instruments, Inc. (PVAN © ). The algorithms used for dual frequency were developed by us and have been published. 16 Absolute volume measurements from the conductance catheter were calibrated with a correction for gain (α). α was defined as the ratio of flow probe stroke volume to the conductance stroke volume. Each mouse was analysed with its individual α.
Statistics A linear mixed model to compare the association of frequency and myocardial resistivity between db/db and wild type was performed. The general linear mixed model is an extension of analysis of variance (ANOVA). The db/db and wild type haemodynamic parameters were compared by Student's paired t test. A p value less than 0.05 was considered significant. Data are presented as means+SE.
Results

Myocardial resistivity
A comparison of db/db and WT myocardial resistivity is shown in table 1. At lower frequencies (1 and 10 kHz) the db/db resistivity was higher than the WT. Table 2 is a comparison between db/db and WT mouse haemodynamics and weights. The diabetic mice have larger body size compared to the WT mice at 11 weeks. Despite the increase in body weight, the afterload (as measured by effective arterial elastance) was similar in both groups. The heart weights and left ventricular volumes were the same. Left ventricular pressure was higher in the db/db mice compared to the wild type mice. Not shown in table 2, the db/db mice had a mean glucose of 246+36 (n=4) and their WT controls had a mean glucose of 82+19 (n=5), which is statistically different. Table 3 is a comparison between db/db and WT mouse measures of systolic function. Using relatively load-independent measures of systolic function, four of five measures show an increase in left ventricular function in the db/db mice compared to WT controls. Table 4 is a comparison between db/db and WT mice measures ORIGINAL ARTICLE Key: BW = body weight; HW = heart weight; HR = heart rate; V ed = LV end-diastolic volume; V es = LV end-systolic volume; P max = maximum LV pressure; P es = LV end-systolic pressure; E a = effective arterial elastance; SV = stroke volume; CO = cardiac output; SW = stroke work; ns = not significant A typical example of the haemodynamic results for a db/db and WT mouse is shown in figures 1a and 1b. As is visibly evident, the db/db mouse had higher pressure, steeper E'max slope, similar diastolic compliance and effective arterial elastance.
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Discussion
This study has demonstrated that, early in type 2 diabetes, there is an enhancement of left ventricular systolic function as detected by multiple load-independent measures of ventricular function and greater pressure generation. This enhancement in function was despite no change in loading conditions and the obesity of the diabetic mice i.e. effective arterial elastance and end-diastolic volume were no different between the diabetic and control mice. There was also no evidence of cardiac hypertrophy early in the diabetic mice to account for our findings since the heart weights were similar between the diabetic and control mice. Thus, this study provides the unexpected finding of enhanced ventricular function early in diabetes when the variable of coronary atherosclerosis is removed.
The diabetic mouse model we studied has been described in the literature since 1979. These diabetic mice were created by a spontaneous mutation in the leptin receptor in the central nervous system, 17 so have been available to the scientific community since long before the development of transgenic mice. However, the increase in left ventricular systolic function is only now being described. This is because the miniaturisation of conductance technology to determine load-independent measures of ventricular function in vivo via pressure-volume analysis is a recent development, 11, 12 and has not been applied to this mouse model in the past.
Previous echocardiographic evaluation of this intact mouse model demonstrated the opposite finding of decreased function in the diabetic mouse. However, fractional shortening as determined by echocardiography is known to be a load-dependent measure of ventricular function. We have demonstrated increased left ventricular pressure early in diabetes in this model, which is known to reduce fractional shortening. Blood pressure was not measured in the echocardiographic study. 9 Thus, previous echocardiographic studies of this mouse model are not necessarily in conflict with our findings.
The isolated perfused db/db murine heart has been shown to generate the same left ventricular pressure, and a reduction in cardiac output, when compared to isolated hearts of wild-type mice. 8 However, the perfusate used in this study contained a marked reduction in the concentrations of glucose, insulin and free fatty acids compared to those known to be present in the intact diabetic animal. Therefore, the isolated heart studies published to date are not representative of the true energy precursor milieu normally found in the db/db model. For future studies, isolated diabetic hearts will need to be perfused with physiological ORIGINAL ARTICLE concentrations of insulin, free fatty acids, and glucose in light of our current findings. Support for our finding of enhanced systolic function early in type 2 diabetes can be found in previous work published on the diabetic Zucker rat. 7 Similar to the db/db mouse, the Zucker rat also has a spontaneous mutation of the central nervous system leptin receptor. Greater generation of left ventricular pressure and its first derivative has been described in this model compared to control isolated preparations. These findings were present even though the perfusate contained sub-physiological concentrations of Insulin. When physiological insulin concentrations were added to the perfusate, the previously described increase in left ventricular pressure and dP/dt was further augmented. In light of these studies in the Zucker rat, our findings of enhanced systolic function in the intact db/db preparation using load-independent measures of systolic function are not surprising.
The observation of increased left ventricular systolic function early in diabetic mice, before the onset of structural damage, has several clinical implications. Patients with type 2 diabetes are known to have an enhancement of glomerular filtration rate (GFR) early in the course of their disease. 18 The mechanism for increased GFR has been postulated to be hyper-filtration due to a reduction in intra-renal vascular resistance, resulting in an increase in single nephron flow. 18 This mechanism would imply a proportionally greater reduction of afferent arteriolar resistance compared with efferent arteriolar resistance. Suggested mechanisms for this haemodynamic alteration have been metabolic and include increased glucose, insulin resistance, glycosylated end-products, elevated growth hormones, glucagons, elevated ketone bodies, intracellular accumulation of sorbitol, and elevated local atrial natriuretic peptide and nitric oxide.
An alternative haemodynamic hypothesis suggested by our results would be greater cardiac perfusion of the kidney early in diabetes due to enhanced left ventricular systolic function. Elevated GFR/single nephron flow could be in part mediated by increased renal perfusion by the myocardium. It would be interesting to examine the left ventricular systolic function of young patients with early type 2 diabetes before the onset of structural heart disease, to see if our findings in mice have clinical relevance.
Patients with longstanding diabetes suffer from retinopathy as well as nephropathy. The mechanism of diabetic retinopathy is also controversial. Several mechanisms have been proposed, including increased glucose, inflammation, glycosylated end-products, and up-regulation of growth factors. 19 However, no haemodynamic explanations have been proposed to date. Enhanced left ventricular systolic function, leading to increased systolic blood pressure and possibly increased retinal blood flow, may explain some of the alterations in the diabetic retina. Support for this hypothesis comes from the decrease in microvascular end points observed in the UKPDS study, 20 in which systolic blood pressure was successfully reduced. It would be of interest to determine whether retinal blood flow is increased in type 2 diabetes, or whether the central nervous system can autoregulate its microcirculation to mitigate against the level of increased pressure found in our study.
We hypothesise that the mechanism for the increase in myocardial contractility is an increase in substrate supply and subsequent energy production. Normally, the heart primarily relies on fatty acid metabolism for energy production, with smaller contributions from glycolysis. In type 2 diabetes, there is increased supply of both free fatty acids and glucose. Although skeletal muscle demonstrates insulin resistance, the myocardium does not, and can still utilise glucose for energy production. 10 Not only is glucose available to the myocardium for energy generation in diabetes, but the increase in both insulin and glucose implies an increased supply of this substrate for energy generation. Free fatty acids are also increased in the diabetic plasma, and the diabetic heart up-regulates its ability to utilise this source of energy production as well. 21 Thus, it is anticipated that there is increased production of acetyl-CoA, the common end product of both the glycolic and beta oxidation pathways. With this increase in substrate to the Krebs cycle, there may be an increase in energy production.
There are several limitations to this study. First, the new hypotheses we present concerning the mechanism of renal and retinal disease in type 2 diabetes are based on a mouse model, with no evidence that a similar mechanism exists in diabetic patients. However, our finding of increased systolic function early in diabetes has not been previously proposed and can be examined in patients in future studies. Second, we have not blocked free fatty acid metabolism and glucose utilisation to see whether we could acutely diminish the increase in left ventricular systolic function that we have observed. Such studies would be important to confirm our suggested mechanism for increases in systolic functionnamely, increased energy production.
In conclusion, we have demonstrated via pressurevolume analysis an enhancement of murine left ventricular systolic function early in type 2 diabetes. These findings occurred despite the diabetic mice having similar pre-load, afterload and heart weights. These findings still need to be examined to see whether they occur in patient populations as well. If confirmed in patients, the value of gene-altered diabetic mice in generating a new hypothesis about haemodynamic mechanisms of disease will be evident.
